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Summary
Background: Primary aldosteronism (PA) is one of the most prevalent 
forms of secondary hypertension, which may be cured by unilateral adre-
nalectomy. Adrenal vein sampling (AVS) is considered the gold-standard 
procedure for distinction between bilateral and unilateral aldosterone hy-
persecretion. However, the procedure is viewed as a technical challenge. 
The objectives of this study were to define the success rate of AVS, and its 
clinical determinants, and to compare the accuracy of high-resolution ad-
renal computed tomography (CT) with AVS.
Methods: In this single-centre retrospective study, patients with bio-
logically proven PA who were referred for AVS between 2009 and 2014 
were included. Adrenal vein catheterisation was considered selective if the 
selectivity index (adrenal vein /  inferior vena cava cortisol) was ≥2.
Results: Data from 68 patients (48% women) were available. The success 
rate of catheterisation in bilateral AVS was 60% (41/68). The significant 
clinical determinants of success were male sex (r = 0.35, p = 0.004), a 
higher body mass index (BMI) (r = 0.54, p = 0.001) and plasma creatinine 
(r = 0.25, p = 0.048) in univariate analysis. In multivariate linear regression 
analysis, only BMI was associated with success (coefficient  = 0.049, 
p = 0.004). CT was discordant with AVS in 53% of patients, and would have 
resulted in inappropriate adrenalectomy in 43% of the patients and inap-
propriate exclusion from surgery in 10% of the cases.
Conclusion: Clinical characteristics such as BMI and sex may influence the 
success rate of AVS. The inaccuracy of CT may result in inappropriate 
treatment proposals if the indication for surgical intervention is based on 
CT only.
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Background
Primary aldosteronism (PA) is one of the commonest 
forms of secondary hypertension. Its prevalence in hy-
pertensives patients is 10% and may rise to 20% in se-
lected patients with resistant hypertension [1, 2]. In this 
selected population, PA may account for one third of 
all cases of secondary hypertension [3]. Among sub-
types of PA, aldosterone-producing adenoma (APA) 
and bilateral adrenal hyperplasia (BAH) are the two 
most prevalent subtypes and are responsible for >95% 
of all PA [1]. Interestingly, the prevalence of APA com-
pared with BAH is higher in centres where adrenal vein 
sampling is available [1]. Early identification and 
 specific treatment of patients with PA is important 
 because these patients carry an increased risk of target 
organ damage and an increased risk of cardiorenal 
complications when compared with essential hyper-
tension patients with similar blood pressure levels [4]. 
Finally, most patients with PA and unilateral aldoster-
one oversecretion benefit from a surgical approach, 
resulting in normalisation of aldosterone secretion or 
blood pressure, better blood pressure control with less 
drugs and a regression of target organ damage [5–8].
The gold standard method for identifying a unilateral 
overproduction of aldosterone is through adrenal vein 
sampling (AVS) [9]. AVS consists of direct assessment of 
hormonal secretion in the adrenal veins and inferior 
vena cava. Although AVS appears to be a straight-
forward technique, it is underused worldwide owing to 
the belief that it is technically challenging, invasive, 
associated with risks and not always necessary [9, 10]. 
As no data regarding clinical determinants of AVS suc-
cess have been published, the purpose of this study 
was to define the success rate of AVS and to identify its 
clinical determinants, as well as to compare the accu-
racy of high-resolution adrenal computed tomography 
(CT) with AVS in a referral centre in Switzerland.
Methods
This study was a retrospective, single-centre-based 
analysis of all patients with PA who were referred to 
the Lausanne University Hospital for AVS between 
2009 and 2014. AVS was proposed for all patients with 
PA in whom adrenalectomy was a possible therapeutic 
option. Antihypertensive drugs were stopped 2 weeks 
prior to AVS, except for spironolactone which was 
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stopped 6 weeks before the intervention. The only 
anti hypertensive drugs allowed before AVS were the 
alpha -blocker doxazosine or calcium channel blockers.
The study was approved by the local institutional 
review committee.
Radiological imaging 
High-resolution contrast computed tomography (CT) 
or magnetic resonance imaging (MRI) were used for 
the radiological definition of normal adrenal glands, 
unilateral adrenal adenoma, bilateral adrenal ade-
noma, unilateral adrenal hyperplasia and bilateral 
 adrenal hyperplasia.
Adrenal vein sampling
AVS was performed under local anaesthesia by the 
same experienced vascular radiologist via a per-
cutaneous right trans-femoral vein approach using a 
standardised protocol. The order of catheterisation 
and blood sampling was proximal vena cava, distal 
vena cava, the left adrenal vein and finally the right 
 adrenal vein. 
High-resolution CT acquisition during the procedure 
was used to localise the tip of the catheter precisely, 
 allowing the distinction between the adrenal vein and 
a hepatic accessory vein when necessary. AVS was per-
formed sequentially without cosyntropin stimulation. 
Samples
Plasma renin activity and plasma aldosterone were 
measured with commercial radioimmunometric 
 assays, (RENCTK (Angiotensin I) RIA, DiaSorin, Salug-
gia, Italy and ALDO RIACT® Kit, Cisbio Bioassays, Codo-
let, France, respectively). Serum cortisol levels were 
measured with FPIA (fluorescence polarisation immu-
noassay) on an AxSYM instrument (Abbott Diagnos-
tics. Lake Forest, Illinois, USA).
Selectivity and lateralisation indexes
AVS was considered successful if right and left adrenal 
venous cortisol concentration was ≥2 (selectivity in-
dex; SI) times higher than the inferior vena cava 
plasma cortisol concentration. Lateralisation of aldos-
terone secretion (defined as the ratio of the higher 
[dominant] over the lower [nondominant] plasma 
aldosterone concentration / plasma cortisol concentra-
tion ratio) was considered present if the lateralisation 
index (LI) was ≥4. These ratio indexes are recom-
manded by the European expert consensus statement 
[9].
Statistic analysis
Statistical analysis was performed using STATA® Data 
Analysis and Statistical Software, version 12.1. In the 
descriptive analysis, the variables are presented as 
mean ± standard deviation or median with interquar-
tile range if data were not normally distributed. Com-
parisons between the groups were performed using χ2 
tests for differences in the proportions of categorical 
variables, and two-sample Wilcoxon rank sum tests for 
ordinal variables and variables that were not normally 
distributed. Spearman rank correlation was calculated 
between physical characteristic and success of adrenal 
vein sampling. For the relationship between success 
rate as the dependent variable and body mass index 
(BMI) categories as the independent variables of inter-
est, we used as predictors in the fully adjusted models 
of age, sex and plasma creatinine. We used a nonpara-
metric test for trend across categories of BMI (nptrend 
function in Stata developed by Cuzick, which is an ex-
tension of the Wilcoxon rank-sum test). All p-values of 
<0.05 were considered statistically significant.
Results
Sixty-eight patients were referred for AVS between 
2009 and 2014. Sixty-six of them had complete AVS and 
radiological imaging data. Baseline demographic char-
acteristics are presented in table 1. Out of all the pa-
tients, 25% had a normal serum potassium level (mean 
3.26 ± 0.55 mmol/l). All patients had hypertension with 
a mean systolic blood pressure of 169 ± 28 mm Hg and 
mean diastolic blood pressure of 105 ± 14 mm Hg. On 
average, patients were taking 2.2 ± 1.2 antihypertensive 
drugs. No adverse events related to AVS were reported.
CT and MRI results
The most common adrenal abnormalities detected 
were left adrenal nodules, in 48% (32/66) of the pa-
tients, followed by right adrenal nodules in 21% of the 
patients (14/66). Seventeen percent of the examina-
Table 1: Baseline demographic characteristics.
n (found)
Gender, male/female 35/33 68
Age, years 47.2 ± 12.1 68
BMI, kg/m2 29 ± 5.6 66
Potassium, mmol/l 3.26 ± 0.55 66
Creatinine, mmol/l 75.5 ± 18.1 63
Office SBP, mm Hg 169 ± 28 25
Office DBP, mm Hg 105 ± 14 25
Number of antihypertensive drugs 2.1 ± 1.2 68
PRA, ng/ml/h 0.06 [0.04; 0.24] 44
PAC, pg/ml 250 [190; 442] 39
Data are presented as means ± standard deviation, except non normally distributed data which are 
presented as medians an interquartiles. BMI = body mass index; PRA = plasma renin activity; PAC = 
plasma aldosterone concentration; SBP = systolic blood pressure; DBP = diastolic blood pressure
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AVS success rate and clinical determinants
Bilateral AVS (SI ≥2 in both adrenal veins) was success-
ful in 60.3% (41/68) of patients. The success rate of left 
adrenal vein catheterisation tended to be higher than 
the right adrenal vein (82% vs 71%, p = 0.11). Male sex 
(fig. 2) and categories of BMI were both associated with 
bilateral AVS success (fig. 3). Bilateral AVS success was 
indeed achieved in 77% of the male population against 
42% in female population. In unavariate analysis, sex, 
BMI and plasma creatinine were associated with cath-
eterisation success rate (table 2). In multi-variate analy-
sis, only a BMI was significally correlated with a high 
success rate, with a high BMI increasing the rate of 
 success (table 3). 
Comparison between AVS and adrenal imaging 
In order to compare results of AVS with the results 
of imaging, we use the cases of the 39 patients with bi-
lateral AVS success. In 53% of cases, AVS results were 
discordant to the results of radiological imaging. The 
nature of the discordant results were as follows: 
2 radiological images showed bilateral abnormalites 
but AVS concluded to unilateral aldosterone secretion, 
2 radiological studies showed no abnormalities but 
AVS concluded to unilateral aldosterone secretion, 11 
radiological studies showed unilateral abnormalites 
but AVS showed no lateralisation of aldosterone secre-
tion. Finally, 6 radiological studies showed unilateral 
abnormalities but AVS indicated contralateral aldos-
terone secretion (fig. 4). 
Surgery and histopathological results (table 4)
Sugery was proposed to patients with lateralised aldos-
terone secretion. In the case of discordant results be-
tween radiological studies and AVS results, the deci-
sion to operate or not was shared with the patient. 
Thirty patients had laparoscopic unilateral adrenalec-
tomy, including 18 on the left side and 12 on the right 
Figure 1: Radiological adrenal gland findings.
Figure 2: Rate of bilateral AVS success in women and men.
Figure 3: Rate of bilateral AVS success according to body 
mass index (BMI).
tions (11/66) showed normal adrenals. Finally, 5% (3/66) 
showed bilateral abnormalities, of which 5% (3/66) 
were bilateral adenomas and 2% (1/66) were bilateral 
hyperplasia. Adrenal imaging results are summarised 
in figure 1.
Table 2: Association between clinical determinants  
and bilateral AVS success.
Success
Age 0.18 (0.15)
Sex 0.36 (0.0039)
BMI 0.54 (0.0001)
Office SBP 0.17 (0.42)
Office DBP 0.026 (0.90)
Creatinine  0.25 (0.048)
Potassium 0.22 (0.080)
ARR 0.24 (0.13)
Data are Spearman’s rank coefficient with associated p-value in 
 parentheses. BMI = body mass index; SBP = systolic blood pressure;  
DBP = diastolic blood pressure; ARR = aldosterone renin ratio
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side. Most histopathological results showed adrenal 
adenoma (22/28) followed by adrenal hyperplasia 
(6/28). Computed imaging was concordant with histo-
pathological reports in 71% of the cases. Two adenoma 
revealed by histopathology were not detected by radio-
logical studies.
Discussion 
This study is the first to report that some clinical char-
acteristics such as BMI, sex or creatinine may influence 
the success rate of AVS. This study also confirms previ-
ous reports showing the high rate of discordant results 
between radiological imaging such as CT scans or MRI 
with functional assessement of aldosterone secretion 
by AVS. Finally, in patients who had one of the adrenal 
glands removed, the results also confirmed that radio-
logical findings show a relatively high number of dis-
cordant results.
Although several determinants of AVS success have 
been reported in the literature, it is surprising that 
patients characteristics have not been reported so far 
[11–13]. In the present study, male sex, a high BMI or a 
high plasma creatinine were significantly associated 
Table 3: Multivariate linear regression analysis of BMI with adrenal vein sampling success.
Dependant variable Predictor variables Coefficient (95% confidence interval) p-value
Bilateral AVS success rate (%) BMI 0.048 (0.016; 0.081) 0.04
Age –0.0049 (–0.020; 0.010) 0.52
Sex 0.14 (–0.27; 0.55) 0.49
Creatinine 0.0047 (–0.0057; 0.015) 0.37
Adjusted R2 = 0.22
Age, sex and creatinine were used as predictors. AVS = adrenal vein sampling; BMI = body mass index
Table 4: Number of laparoscopic adrenalectomies  
and histological findings. 
Adrenalectomy (n) 48% (30/68)
Right adrenalectomy 40%(12/30)
Left adrenalectomy 60% (18/30)
Histology reports (n) 30/30
Adrenal adenoma     74%
Adrenal hyperplasia 20%
Normal adrenal  7%
Figure 4: Comparison of radiological and AVS findings. AVS = adrenal vein sampling.
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with a greater success rate of having both adrenal veins 
catheterised. Only BMI persisted as a significant suc-
cess factor in the multivariate analysis. This probably 
reflects the effect of sex on creatinine or BMI, which 
were both higher in men. The positive effect of BMI 
may be secondary to the increased intra-abdominal 
pressure found in obese patients [14]. Indeed, it has 
been shown that elevation in intra-abdominal pres-
sure is associated with haemodynamic changes, such 
as renal venous pressure and decreased venous return, 
renal or visceral blood flow [15, 16]. This increase in ab-
dominal pressure may well have an impact on adrenal 
vein pressure and flow, which may increases adrenal 
vein diameter and facilitate catheterisation.
In our retrospective study, the overall success of bilat-
eral catheterisation of adrenal veins was 60%. In the 
literature, the rate of success ranges between 8% to 
98%, which largely depends on the implementation of 
a standardised operating procedure, the use of guiding 
CT during the procedure of adrenal vein sampling, the 
presence of an experienced interventional radiologist 
and a multidisciplinary approach [17]. Our success rate 
is in the range of the German Conn’s registry after they 
implemented standardised procedures in order to in-
crease the rate of success [17]. Locally, the presence of 
a single experienced interventional radiologist using 
a standardised protocol with the help of a CT scan to 
 localise the adrenal veins may explain the similar suc-
cess range. The cutoff value of the SI is logically very 
important in determining the success of AVS: the 
higher the cutoff, the lower the rate of success [17, 18]. In 
the AVIS study, Rossi et al. showed that most of the 
 major international referral centers are using different 
cutoffs to assess selectivity [19]. In 2014, the expert con-
sensus statement on the use of AVS was published and 
clearly defined cutoff values which should be used for 
AVS with or without stimulated conditions [9]. The SI 
value for unstimulated AVS is recommended to be ≥2, 
which we used as a referrence in our study. 
In order to increase the AVS success rate, several pro-
posals have been made, such as assessing cortisol dur-
ing the AVS procedure (intra-procedural cortisol meas-
urement, IPCM). A few studies showed that IPCM 
increases success rate and can avoid a second proce-
dure in the event of bilateral AVS failure in the first 
place [20, 21]. Unfortunately, this method has some dis-
advantages. Indeed, direct cortisol assessment re-
quires time (20–120 minutes) during which the patient 
is required to remain in the recovery room with a fem-
oral shealths in situ, which may increase the risk of 
complications such as adrenal infarct, adrenal vein 
thrombosis, bleeding and infection. Some centres use 
a portable cortisol analyser that can be operated di-
rectly in the radiology room, and thereby reduce the 
transport time to the laboratory. Unfortunately, the 
portable analysers are very expensive. The use of 
plasma metanephrine instead of cortisol to assess the 
selectivity of AVS is a new promising method which 
may replace cortisol in the future [22]. 
Finally, high-resolution CT can be used during the AVS 
procedure to provide visual and anatomical conforma-
tion of correct cannulation and thus reduces the risk of 
failure, particularly from the right adrenal vein [23].
AVS and CT/MRI adrenal imaging discrepancies 
The distinction between unilateral or bilateral excess 
aldosterone secretion is essential to guide the choice of 
the most adequate treatment in patients with PA in 
whom surgery is an option. If imaging studies, such a 
CT scan or MRI have the advantage of availability, both 
may either miss aldosterone producing microadeno-
mas resulting in inappropriate exclusion of surgery or 
detect nonfunctionning adrenal adenomas, which 
may lead to unnecessary adrenalectomy. Indeed, Kem-
pers et al. published a systematic review based on more 
than  950 patients and 40 studies, which revealed that 
a discrepancy between AVS and adrenal imaging was 
present in 37.8% of the cases [24]. In our study, we found 
that 53% of adrenal imaging that did not match with 
the AVS results. Forty-three percent of these patients 
would therefore have been operated inappropriately, 
of whom 11 (28%) showed a unilateral abnormality on 
adrenal imaging but no aldosterone lateralisation on 
AVS, 6 patients (15%) showed lateralisation of secretion 
on AVS but on the opposite side compared with adrenal 
imaging and finally 4 patients (10%) in whom adrenal 
imaging showed either an absence of abnormality or 
bilateral abnormality. However, CT and MRI remain 
important for the detection of anatomical variants be-
fore an adrenalectomy, in patients for whom PA is 
caused by a rare adrenal carcinoma or in patients 
whose health prohibits an AVS procedure. In these 
cases, adrenal imaging should still be considered a 
complementary technique.
Interestingly, the discordance between radiology and 
histopathology fell down to 29%. This might reflect 
therapeutic decisions where adrenalectomy was pro-
posed only if AVS and radiological images were con-
cordant. The definite proof of AVS superiority over ra-
diological studies as a decision tool as to whether to 
operate would have been obtained if follow-up data on 
hypertension control or cure in patients with discord-
ant results (clear lateralisation of aldosterone secre-
tion with no or controlateral adrenal nodule on radio-
logical images) were available.
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Limitations
There are several limitations in our study. First, the 
study was retrospective, limiting the level of evidence. 
However, as reviewed recently, most of the published 
studies on this topic are retrospective [9]. As a result of 
the retrospective nature of the study, some clinical 
data were missing for some of patients, especially 
when patients were referred from other centres. Fi-
nally, AVS was performed without cosyntropin infu-
sion, which is used for enhancing plasma cortisol 
 concentrations, reducing stress-induced cortisol and 
aldosterone secretion during sequential AVS. However, 
there is no consensus so far on the use or non-use of 
cosyntropin infusion before or during AVS and some 
centers have abandoned cosyntropin infusion as it 
may increase the number of cases identified as bilat-
eral [9, 10].
Conclusion
Clinical characteristics of patients with PA may influ-
ence the rate of success of AVS and may prepare the 
inter ventional radiologist for a difficult procedure. The 
use of a CT scan as a decision tool to perform unilateral 
adrenalectomy is not sufficient and biological assesse-
ment of aldosterone secretion lateralisation with AVS 
is essential in the work-up of patients who are candi-
dates for adrenalectomy. Finally, follow-up studies to 
determine the rate of cure and control of hypertension 
are needed in order to define the use of AVS and radio-
logical studies as guides to treatment in patients with 
primary aldosteronism.
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